BillionToOne (BLLN) Preferred Stock Liabilities (2024 - 2025)
BillionToOne (BLLN) posted Preferred Stock Liabilities of $419.4 million for Q3 2025, little changed sequentially from $419.4 million in Q4 2024, and little changed YoY from $419.4 million in Q3 2024.
BillionToOne (BLLN) Preferred Stock Liabilities (2024 - 2025) Analysis & Trends
BillionToOne has reported Preferred Stock Liabilities for 2 years, with the latest figure at $419.4 million in Q3 2025.
- Quarterly Preferred Stock Liabilities changed 0.0% year-over-year to $419.4 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $419.4 million (changed 0.0% YoY) and the FY2024 annual result came in at $419.4 million, up 68.08% from the prior year.
- Preferred Stock Liabilities held at $419.4 million in Q3 2025 per BLLN's latest filing, from $419.4 million in the prior quarter.
- Over five years, Preferred Stock Liabilities peaked at $419.4 million in Q3 2024 and troughed at $419.4 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | - |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | - |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | - |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | - |
| 10 | BillionToOne | 6.82 Bn | 6.28 Bn | 79.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 419.41 Mn |
| Dec 31, 2024 | 419.41 Mn |
| Sep 30, 2024 | 419.41 Mn |